Efficacy and safety of stem cells in the treatment of ischemic stroke: A meta-analysis.
Yu XiongXiumei GuoWen GaoChuhan KeXinyue HuangZhigang PanChunhui ChenHanlin ZhengWeipeng HuFeng ZhengHao YaoPublished in: Medicine (2024)
Stem cell therapy reduces mortality and improves the neurological prognosis of ischemic stroke patients. However, due to the different types of stem cells used and the limited data in the reported studies, the safety of clinical applications of stem cells in patients with ischemic stroke must be carefully evaluated. Future randomized controlled trials with large sample sizes from controlled cell sources are warranted to validate this finding.
Keyphrases
- stem cells
- cell therapy
- atrial fibrillation
- end stage renal disease
- randomized controlled trial
- ejection fraction
- newly diagnosed
- prognostic factors
- peritoneal dialysis
- single cell
- cardiovascular events
- type diabetes
- machine learning
- systematic review
- clinical trial
- cardiovascular disease
- big data
- risk factors
- coronary artery disease
- mesenchymal stem cells
- replacement therapy
- smoking cessation
- case control
- patient reported